Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES

(GILD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about GILEAD SCIENCES
08/16GILEAD SCIENCES : European Medicines Agency Validates Marketing Application for ..
AQ
08/15European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos
DJ
08/15STEALTH BIOTHERAPEUTICS : Reports First Half 2019 Financial Results and Recent B..
AQ
08/15GILEAD SCIENCES : Québec Provides Access to Biktarvy® for the Treatment of HIV
AQ
08/13GILEAD SCIENCES : Report
CO
08/12GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
AQ
08/12GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
AQ
08/09MARKET SNAPSHOT: Dow Ends Friday Trade Lower But Indexes Chipped Away At Ugly..
DJ
08/09GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
BU
08/08GILEAD SCIENCES : Statement on U.S. Food and Drug Administration Advisory Commit..
AQ
08/08AGENUS : FDA Accepts AGEN2373 IND, Triggering $7.5 Million Milestone
DJ
08/07NOVARTIS : Medicare Moves to Cover Costly Cell Therapies
DJ
08/07GILEAD SCIENCES : Statement on U.S. Food and Drug Administration Advisory Commit..
BU
08/07GILEAD SCIENCES : Medicare to cover expensive cancer cell therapies
RE
08/07Patient groups push back against Gilead's pricey HIV prevention treatment
RE
More most relevant news
All news about GILEAD SCIENCES
08/16GILEAD SCIENCES : European Medicines Agency Validates Marketing Application for ..
AQ
08/15European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos
DJ
08/15STEALTH BIOTHERAPEUTICS : Reports First Half 2019 Financial Results and Recent B..
AQ
08/15GILEAD SCIENCES : Québec Provides Access to Biktarvy® for the Treatment of HIV
AQ
08/13GILEAD SCIENCES : Report
CO
08/12GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
AQ
08/12GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
AQ
08/09MARKET SNAPSHOT: Dow Ends Friday Trade Lower But Indexes Chipped Away At Ugly..
DJ
08/09GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
BU
08/08GILEAD SCIENCES : Statement on U.S. Food and Drug Administration Advisory Commit..
AQ
More news
Sector news : Bio Therapeutic Drugs
08/15European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos
DJ
08/12REGENERON PHARMACEUTICALS : Two Experimental Ebola Drugs Reduce Mortality Rate
DJ
08/08Sarepta says adverse event report for DMD gene therapy erroneously submitted
RE
08/08AGENUS : FDA Accepts AGEN2373 IND, Triggering $7.5 Million Milestone
DJ
08/07Hedge fund Hoplite Capital plans to shut down - letter
RE
More sector news : Bio Therapeutic Drugs
Official Publications
Upcoming event on GILEAD SCIENCES